AI assistant
PRAIRIE LITHIUM LIMITED — Director's Dealing 2011
Feb 10, 2011
65572_rns_2011-02-10_2933b0e8-2606-45f0-9125-61039c122537.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity ZYL Limited ABN 15 008 720 223
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Dr Eric Lilford |
|---|---|
| Date of last notice | 30 September 2010 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct Interest |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. | Dr Eric Vernon Lilford ATF <Dr EVL & CoTrust> |
| Date of change | Fully paid Ordinary Shares – 9 February2011 |
| No. of securities held prior to change | 5,333,333 fully paid ordinary shares5,333,333 unquoted options exercisable at 3cents per share and expiring on 30 September2012 |
| Class | Fully paid Ordinary Shares |
| Number acquired | 2,500,000 fully paid ordinary shares |
| Number disposed | Nil |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | Fully paid ordinary shares – No considerationpayable as the shares were issued to Dr EricLilford pursuant to the satisfaction of a keyperformance hurdle in relation to theExecutiveServiceAgreementexecutedbetween the Company and Dr Eric Lilford onor about 15 August 2009 – estimatedvaluation based on prevailing market price atthe date of allotment |
|---|---|
| No. of securities held after change | 7,833,333 fully paid ordinary shares |
| Nature of changeExample: on-market trade, off-market trade, exercise of options,issue of securities under dividend reinvestment plan, participation inbuy-back | Fully paid ordinary shares acquired pursuantto the satisfaction of a key performancehurdle in relation to the Executive ServiceAgreement executed between the Companyand Dr Eric Lilford on or about 15 August2009 |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder(if issued securities) | N/A |
| Date of change | N/A |
| No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract inrelation to which the interest has changed | N/A |
| Interest acquired | N/A |
| Interest disposed | N/A |
| Value/ConsiderationNote: If consideration is non-cash, provide detailsand an estimated valuation | N/A |
| Interest after change | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? | Yes |
| If so, was prior written clearance provided to allow the tradeto proceed during this period? | Yes |
| If prior written clearance was provided, on what date was thisprovided? | 28 January 2011 |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3